Acer Therapeutics Inc

NASDAQ:ACER   3:59:40 PM EDT
3.06
-0.04 (-1.29%)
Products

Acer Therapeutics Plans NDA Submission For Acer-001 In Q3 2021 Following Pre-NDA Meeting With FDA

Published: 05/25/2021 12:58 GMT
Acer Therapeutics Inc (ACER) - Acer Therapeutics Plans NDA Submission for Acer-001 in Q3 2021 Following Pre-nda Meeting With FDA.